Eightco announced the appointment of Nicola Caiano to its Board of Directors. Caiano brings over three decades of expertise in financial strategy, capital markets, and investment management, further strengthening Eightco’s strategic vision and growth trajectory. Caiano currently serves as Chief Financial Officer at Cytometric Therapeutics
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OCTO: